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Carcinogenicity of Airborne Fine
Particulate Benzo(a)pyrene:
An Appraisal of the Evidence and the
Need for Control
by F. Perera*
Benzo(a)pyrene (BaP) originating from fossil fuel and other organic combustion processes is
largely adsorbed on fine particulate and hence is a widespread atmospheric pollutant. Available
emissions and air quality data are based on the total weight of particulate matter without
reference to size and give little information on trends and concentrations of fine particulate
BaP. Greater reliance on coal, synfuels and diesel fuel for energy production and transportation
will significantly increase ambient levels of BaP.
Because of the particulate size, BaP is substantially deposited in the lower lung and readily
eluted into surrounding tissue. After elution in the lung, BaP is metabolically activated to its
electrophilic, carcinogenic form by a complex enzyme system whose activity is increased by
prior exposure to air pollutants, cigarette smoke and certain drugs. The resultant diol epoxide
metabolite has been shown to bind covalently with the DNA of the lung. In experimental
animals, BaP is a potent initiating carcinogen whose action is enhanced by sulfur dioxide,
promoting agents and carrier fine particles. The effect of small, divided doses of BaP has been
shown to be greater than that of a single high dose; no threshold has been established.
Epidemiological studies show that mixtures containing BaP (such as urban air, industrial
emissions and cigarette smoke) are carcinogenic and may interact synergistically. Occupa-
tional studies indicate that the action of BaP-containing mixtures is enhanced in the presence
of S02-
However, quantitative risk assessment for BaP is precluded by problems in extrapolating to
the general population from small-scale animal studies; uncertainties in findings ofepidemiolo-
gy; and imprecise exposure data. Existing stationary and mobile source controls preferentially
remove coarse particulate matter and are inefficient collectors of fine particulate BaP. In the
current absence of health and environmental standards for BaP, there is little incentive to
control BaP emissions. BaP meets the criteria for regulation under the Clean Air Act; however,
no such BaP standards have yet been proposed.
Introduction
This paper contains a broad review of the
literature pertaining to the carcinogenicity ofenvi-
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ronmental BaP. The discussion ranges from recent
research on the mode of action of BaP to the
ambient levels of this pollutant and the technolo-
gies that may be used to control emissions from
major sources. The review is set in the context of
present policies that are predicted to substantially
increase concentrations of atmospheric BaP.
The purpose of the paper is to summarize some
ofthe major findings since 1972 when the National
Academy of Sciences (NAS) published a compre-
hensive review of BaP in its report entitled
163Particulate Polycyclic Organic Matter. During the
last eight years, for example, there have been
major advances in understanding of the impor-
tance ofthe fine particulate fraction ofair pollution
with which BaP is largely associated as well as of
the molecular processes involved in the carcinoge-
nicity of BaP.
For background reading, the reader is referred
to two basic references: Polycyclic Hydrocarbons
and Cancer, Vols. 1 and 2 (1) and Carcinogenesis,
Vols. 1 and 3: Polynuclear Aromatic Hydrocarbons
(2).
Origin, Physical and Chemical
Properties of BaP
Formation and Use as an Index
Benzo(a)pyrene is a polycyclic aromatic hydro-
carbon consisting of five aromatic rings. BaP is
formed during combustion of any organic material
such as fossil fuels. At high temperatures of com-
bustion (greater than 400-500° C) organic fragments
or radicals are formed which subsequently com-
bine to form BaP [Eq. (1)] (3, 4). Following release
from the combustor flame as a vapor, BaP either
condenses onto inorganic particles or coalesces to
form particles of pure condensate (5). Other carci-
nogenic polycyclic aromatic hydrocarbons (PAH)
are formed in the same process.
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There is reasonably good correlation of various
PAH with BaP in the emissions from certain sourc-
es; this fact, combined with the availability of ana-
lytical methods for BaP, has led to the use of BaP
as an indicator for PAH and even for the potential
carcinogenicity of air pollution (6-8). However, the
observation that the correlation between PAH and
BaP varies by location (9, 10) as well as the fact
that many non-PAH carcinogens are present in air
(11-13) argue that BaP is a useful indicator for
both PAH and carcinogenicity ofair only in certain
circumstances (10, 14). Therefore, BaP will be
treated here as an important atmospheric carcino-
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gen in its own right: it is the quantitatively most
important carcinogen in soot arising from fossil
fuel burning (5, 6) as well as a major initiating
carcinogen in cigarette smoke (7), in coalgasification
effluent and coke oven emissions (15).
Emission Sources
Man-made BaP arises from fuel combustion by
mobile sources such as gas and diesel-powered ve-
hicles and stationary sources including heat and
power generation, refuse burning, and industrial
activities (4). EPA estimates that in 1975, 2% of
BaP came from mobile sources, 4% from station-
ary combustion of oil, and 80% from combustion of
coal (16).
According to the National Academy of Sciences,
about 1300 tons of BaP are emitted by stationary
sources each year (Table 1).
All of the data in Table 1 are based on very
limited information and are therefore of question-
able validity. In particular, Guerin (5) and Baum
(9) have pointed out that the data for coal burning
power plants may seriously understate actual
amounts of BaP released. First the figure of 1.0
ton per year is based on 1960 data and does not
take account of probable increases in release of
BaP as a result ofcontrol measures to meet EPA's
nitrogen oxide standard for fossil fuel steam gen-
eration plants (17). Second, since BaP is released
in vapor state, the conventional stack sampling
system that does not use an organic vapor adsor-
bent fails to capture a significant proportion of
BaP (18). Jones et al. report from two to ten times
as much polycycic organic matter (POM) measured
in effluents using an adsorbent sampler compared
to that measured by conventional techniques (5,
19). BaP emissions may therefore be an order of
magnitude greater than those predicted by tradi-
tional methods.
Table 1. BaP emitted by stationary sources.a
Source BaP,
tons/yr
Heat and power generation
Coal (residential furnaces) 420.0
Coal (intermediate units) 10.0
Coal (coal-fired steam power plants) 1.0
Wood 40.0
Oil 2.0
Gas 2.0
Industrial plants
Petroleum and asphalt 7.0
Coke production 200.0
Refuse burning 600.0
Total 1282.0
aBased on NAS data (4).
Environmental Health PerspectivesFurthermore, it is important to recognize that
because BaP generally takes the form offine, rela-
tively weightless particulates, even substantial in-
creases in respirable BaP will not be reflected in
gross tonnage figures such as in Table 1. (Fine
particulates are here defined as those smaller than
several micrometers in diameter.)
Three sources in Table 1 are expected to in-
crease atmospheric levels of BaP significantly ei-
ther as a result of the present national energy
program or as an initiative to achieve motor vehi-
cle fuel economy standards. These are stationary
combustion of coal and synthetic fuels (synfuels)
for production ofheat and energy and the increased
use of diesel fuel by automobiles.
Coal burning currently produces more BaP than
any other stationary source (4) and is estimated to
produce more than halfofman-made nitrogen oxide
emissions; and substantial amounts of trace ele-
ments and radionuclides (20, 21). Depending on
the type of coal and combustion efficiency, a coal
burning power plant can emit from 19400,000 i±g/106
BTU (6); hourly emissions can be as high as 50 mg
BaP for a plant rated from 1 to 2 x 106 lb steam/hr
(5). Wilson et al. (22) have reported that 12.9 ng/m3
ofBaP was measured in the stack ofa coal burning
power plant while 16.2 ng/m3 and 8.2 ng/m3 ofBaP
were found in the plume at distances of 0-5 and
5-10 miles from the plant.
In 1977, President Carter called for a doubling
of coal use in power plants by 1985 (23). To date,
over 100 oil-burning facilities have received pro-
posed orders to convert to coal under the Indus-
trial Power Plant Fuel Use Act (IPPFUA) and the
Energy Supply and Environmental Coordination
Acts (ESECA), and thirteen final orders have been
issued under ESECA (24). Last spring, Congress
considered legislation requiring an additional 50
power plants to shift to coal use (25). As an incen-
tive for conversion, President Carter proposed to
give $4 billion to utilities that shift to coal (26).
Utilities now burn over 400 million tons of coal
to produce about 44% of the nation's electricity.
Based on three energy scenarios, the OTA (1979)
projects a 70-90% increase in utility coal combus-
tion by 1985, growing to 140-250% by 2000 (21).
For residential and commercial sources, OTA (1979)
predicts a doubling by the year 2000 and as much
as a tripling by 1985 in industrial coal (21). Both
are already very significant sources of BaP (27).
Combustion of diesel motor fuels yields widely
varying amounts of BaP (from virtually undetect-
able levels up to 1,687 ,ug/min) depending upon
factors such as efficiency ofoperation, level ofmain-
tenance, workload, etc. (28). For example, Hange-
brauck et al. (29) reported a significantly higher
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BaP emissions factor for diesel (690 ,ug/gal fuel)
than for gasoline-powered automobiles (170 ,ug/gal
fuel) and trucks (460 ,ug/gal fuel). According to
EEA (30), however, the best estimate ofBaP emis-
sions from diesel automobiles is 38 pxg/l. (or 106
,ug/gal) ofdiesel fuel burned. In one study, particu-
late emissions from diesel automobile engines were
estimated to contain ten times the amount of BaP
found in emissions ofgasoline powered cars equipped
with catalytic converters (31). Another report es-
timates BaP in exhaust from a light-duty diesel
vehicle to be 10-60 times greater than in exhaust
from a catalyst controlled light-duty gasoline vehi-
cle (32). As with coal emissions, the BaP is found
in a mixture offine particulate sulfate, nitrate, and
organic substances, trace metals, along with gas-
eous sulfur and nitrogen oxides (33).
Several American automobile manufacturers in
search of greater fuel economy have announced
their intention to increase diesel production so that
about 25% of new automobiles sold in the U.S. by
1990 will be diesels (34). This projection is troubling
in light of existing evidence of the ability of ex-
tracts of diesel emissions to cause mutations and
DNA damage in tests widely considered to be in-
dicators of human carcinogenicity (35, 36).
The third major potential source of carcinogenic
BaP is the production and combustion of synthetic
fuels or "synfuels" (5). Synfuels include fuels de-
rived from the liquifaction or gasification of coal,
oil shale, and tar sands. According to EEA (30),
synfuels are potentially large sources of polycyclic
organic compounds (such as BaP) because the de-
sired gaseous or liquid product is one which con-
tains a large proportion ofcombustible organic mat-
ter.
Based on limited data available, Guerin (5) has
estimated that an industry processing 106 tons of
coal per day will produce approximately 100 metric
tons (110 tons) of BaP each year. He states that
coal- and shale-derived crude oils contain two to
three times more BaP than petroleum crudes and
characterizes synfuels as a "potentially massive"
new source of environmental PAH's (5).
In June 1980, Congress enacted legislation to
create a twenty billion dollar synthetic fuel pro-
gram for the U.S. aimed at producing 2.0 million
barrels per day by 1992. The "Synfuels" Bill pro-
vided that Congress can act on an additional 66
billion in 1986. Federal financing has been approved
for three commercial scale projects.
Citing a lack of adequate understanding of both
emissions and the effect of controls for synfuels,
EPA and the Department of Energy hazard no
estimation of future levels of BaP from synfuels
combustion (30, 37). Nor are there more than rough
165estimates of future BaP levels from increased coal
burning or diesel fuel combustion because of the
shortcomings of the data described earlier.
Concentrations in Air and Particle
Size Distribution
Ambient Air Concentrations. Available data
on ambient concentrations of BaP are also of lim-
ited value in estimating health hazards. These data
are largely confined to several large-scale monitor-
ing studies by Sawicki and co-workers in 1958 and
1959 and data collected by the National Air Sur-
veillance System (NASN) between 1966 and 1972
(17). The NASN data consist of those from 250
stations from 1966 to 1970 and only 40 stations
between 1970 to 1972 (27). Large areas of the
United States have never been monitored for BaP
(30).
Table 2 gives BaP values for U.S. communities
and selected cities including those measured in
highlypolluted air, cigarette smoke,* soil, and water
for comparison. Particularly striking is the wide
range of concentrations among communities stud-
ied (0.05-75 ng/m3 in 1958) which is masked by the
annual average figure of6 ng/m3 for the same year.
Data collected in 1959 by Sawicki (39) (Table 3)
give a better idea ofthe great intercity differences
in BaP that existed primarily due to heavy coal
burning in cities like Montgomery, Alabama, and
Altoona and Youngstown, Pennsylvania.
According to EPA, annual average BaP air con-
centrations were reduced significantly between 1966
and 1972-by 55% in coke oven cities and 77% in
non-coke oven cities (27). Yet in 1975, EPA stated
that annual average seasonal concentrations still
ranged from less than 1 ng/m3 in nonurban areas to
50 ng/m3 in urban areas with short-term or local
concentrations reaching as high as 100 ng/m3 (17).
*One cigarette contains an estimated 10-50 nanograms (ng) of
BaP so that cigarette smoking-even so-called "passive"
smoking-is a concentrated source of the pollutant (4).
Table 2. Measured concentrations of benzo(a)pyrene.
BP concentration Year Reference
Air (ng/m3
U.S.A. (100 large urban communities)
U.S.A. (100 large urban communities)
U.S.A. (33 large urban communities)
U.S.A. (large cities):
Winter
Summer
U.S.A. (121 urban NASN sites)
U.S.A. (nonurban sites)
U.S.A. (cities with coke ovens)
U.S.A. (cities without coke ovens)
U.S.A. (selected cities)
New York City
Buffalo
Pittsburgh (heavy coal use)
Birmingham (heavy coal use)
Great Britain:
London
Liverpool and North Wales
Belfast
Japan: Osaka
Air: Highly Polluted (ng/m3)
Urban traffic
Tunnel
Coal-fired power plant (workers' atmosphere)
Coke oven
Battery
Topside
Side and bench
0.05-75
6.6
3.3
6.0-74.0
0.3-6.0
2.4
2.3
2.0
0.4
4.7
2
2.8
0.6
4.1
3.6
3.0
0.1-3.5
4.2
14; 6
18
' 54
7-77
18-37
26 (rural) - 79.0 (urban:
extreme values)
1958
1958-59
1966-67
1967
1968
1969
1970
1959
1966
1972
1966
1972
1966 (ann. avg.)
1969 (ann. avg.)
1970 (ann. avg.)
1976 (2 wks.)
1969 (ann. avg.)
1969; 1970 (ann. avg.)
1966 (ann. avg.)
1968
1954-55
1961-62
1968
2.5-6.5
690
-30-390
216,000
16,000
18,000
7,000
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(7)
(38)
(38)
(38)
(27)
(27)
(27)
(39)
(27)
(27)
(27)
(27)
(17)
(17)
(17)
(40)
(17)
(17)
(17)
(7)
(41)
(7)
(42)
(38)
(38)
(38)
(38)
(43)
(44)
(44)
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BP concentration Year Reference
Gas works
retort houses 3,000 (38)
above retorts 220,000 (38)
Rooftarring 14,000 (38)
Cigarette smoke (,ug/100 cigs.) 0.5; 1.0; 1.2; 2.0; 7.5-12.5 (38)
(ng/cig.) 10-50 (4)
(ng/20 cigs.) 400 (avg. forfiltered and unfiltered) (44)
700 (unfiltered) (44)
600 (unfiltered) (8)
Urine of smoker (ng/l.) 0.55 (45)
Water (,ug/m3)
Drinking 0.1-23.4 (6)
Surface 0.6-114 (6)
Soil (,ug/kg)
Nonindustrial 0-127 (6)
Towns and vicinities 0-939 (6)
Polluted by coal-tar pitch 650,000 (6)
Food (p.g/kg)
Meat
Barbecued 2.6-11.2 (6)
T-bone steak 50.4 (6)
Smoked meat 0.02-14.6 (6)
Meat; sausage (broiled) 0.17-0.63 (6)
Vegetable oils
Crude 0.9-15 (6)
Refined 0.4-36 (6)
Margarine 0.2-6.8 (6)
Vegetables
Tomatoes 0.2 (6)
Salad 2.8-5.3 (6)
Spinach 7.4 (6)
Fruit
Apples 0.1-0.5 (6)
Other 2-8 (6)
Cereals 0.2-4 (6)
Beverages
Coffee 0.1-4.0 (6)
Tea 3.9-21.3 (6)
Table 3. BP concentrations in urban sampling sites for January through March 1959.a
High BP Low BP
Urban sampling site BP, ng/m3 air Urban sampling site BP, ng/m3 air
Montgomery, Ala. 24 Little Rock, Ark. 1.5
Indianapolis, Ind. 26 Glendale, Calif. 0.8
Des Moines, Iowa 23 San Jose, Calif. 0.6
Portland, Maine 21 Miami, Fla. 1.9
St. Louis, Mo. 54 Shreveport, La. 0.7
Charlotte, N.C. 39 Jackson, Miss. 1.2
Cleveland, Ohio 24 Las Vegas, Nev. 1.4
Youngstown, Ohio 28 Bismarck, N. Dak. 0.4
Altoona, Pa. 61 Tulsa, Okla. 1.0
Columbia, S.C. 24 Dallas, Tex. 1.4
Chattanooga, Tenn. 31 Houston, Tex. 1.6
Knoxville, Tenn. 24 Salt Lake City, Utah 0.5
Richmond, Va. 45 Burlington, Vt. 1.0
Wheeling, W. Va. 21 Cheyenne, Wyo. 1.2
aData ofSavicki (39).
167 December 1981As with BaP emissions data, it is very important
to recognize the inability ofexisting ambient moni-
toring data to reflect even substantial increases or
decreases in concentrations of deeply respirable
fine particulate BaP. This is because the BaP mea-
sured is that separated from total particulate ma-
terial collected rather than that associated with
fine particulates (46). The method of sampling in-
volves extraction of solvent soluble organics from
a portion of the high volume sampler filter on
which are collected all particles from 0.002-500 ,um
in diameter. Therefore, preferential control of the
numerically fewer large particles containing BaP
could cause a decline in ambient BaP as currently
measured without any real reduction in health haz-
ard. Hence, one must view data on BaP trends
with caution in assessing health risk.
On another level, the accuracy and precision of
the analytical methods used to measure ambient
BaP are such that levels reported in Tables 1 and 2
may be in error by at least an order ofmagnitude.
Significant loss of BaP (as high as 15-40%) can
occur by evaporation and photodegradation during
collection, storage (for purpose ofpooling samples),
and analysis (47). Estimates of the accuracy of
ambient analytical methods range from ± 25% (9)
to + 200-400% (15). The need to improve BaP
monitoring and analytical methods to give accurate
particle size-related BaPconcentrationsisespecially
urgent in light of anticipated increases in emis-
sions (5, 21).
Particle Size Distributions. Investigations of
the size distribution of BaP-containing particles
consistently show that the great majority ofBaP is
associated with particles smaller than 1-2 microm-
eters in aerodynamic diameter and is therefore
capable of penetrating into the alveoli. [For pur-
poses ofclassification, particles are assigned a func-
tional (aerodynamic) diameter equivalent to that of
a spherical particle that settles at the same rate as
the particle considered.] In the Pittsburgh area,
more than 75% of the mass of PAH is in the form
of particles less than 2.5 ,um (48), while in Buda-
pest, as in Canadian cities studied, the majority of
PAH was associated with fine particles (49-51).
Nevertheless, certain sources can emit substan-
tial amounts of BaP in association with larger non-
respirable size particles. In fact, according to Sawicki
(38) Masek has reported that non-respirable dust
fractions monitored at several coking plants con-
tained more BaP than the respirable fractions (52).
According to Natusch and Tomkins, however, in
emissions from coal-fired power plants, BaP is pref-
erentially adsorbed onto the surface of fine fly ash
particles in the stack along with various toxic and
carcinogenic trace elements (18, 53).
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As illustrated in Figure 1, the size distribution
ofBaP is especiallyrelevantto assessment ofhealth
hazard in that most ofthe substance is found in the
particulate most likely to be deposited in the bron-
chioles and alveoli of the lung (28). Clearance of
particulate fromthis compartment ofthelung(mainly
by macrophages) is relatively inefficient-ranging
in time from days to years (56). Clearance is meas-
urably impaired by cigarette smoking. For exam-
ple, smokers who inhaled particles with a mass
median aerodynamic diameter of 2.8 ,um retained
about five times more dust than nonsmokers a
year after inhalation (57).
Other Physical and Chemical Properties
Relevant to Biological Effects
Stability in the Atmosphere and Long-Range
Transport. BaP is removed from the atmosphere
by reactions with atmospheric oxidants, sulfur ox-
ides and oxygen (4, 9). According to Kotin and
Falk (28), however, BaP is relatively stable in air:
even in a strong oxidizing atmosphere its rate of
disappearance is lower than that of many other
hydrocarbons. Depending on the presence of sun-
light and the nature of the carrier particle, the
half-life of BaP may range from less than a day to
several days (4).
Particles of0.1-1 jim size may have mean atmo-
spheric residence times of one week to several
months (58, 59). Evidence of the long atmospheric
residence time of fine particulates is the observa-
tion ofpolycyclic organic matter derived from human
activity as far as 2500 km from its source (60). The
potential hazard from long-range transport of BaP
and other organics has received far less attention
than that of acid sulfate and nitrate fine particles
also arising from the combustion of fossil fuels.
Long range transport means that BaP is a more
widespread pollutant than previously thought whose
levels will increase alongside those ofSO2 and NO2.
Elution ofBenzo(a)pyrene. Another important
property ofBaP is that the substance is both read-
ily adsorbed on the surface of soot and flyash and
efficiently eluted upon deposition in the lung (4).
Animal studies have demonstrated that BaP dis-
solves out of the carrier particulate into the mac-
rophages and surrounding tissue (61). Elution is
rapid and extensive for particles larger than 0.04-0.1
jim, increasing with particle size (4, 28). According
to Coffin, the slower rate of BaP elution from the
very small particles allows a slow, steady release
of BaP to the target tissues which may increase
the carcinogenic effect (62).
Elution may take place after transport to other
sites of the lung. Saffiotti and colleagues (63) have
Environmental Health Perspectivesdemonstrated in experimental animals that the
macrophages carry BaP-containing particles from
the peripheral lung, where they are deposited, to
the upper segments of the respiratory tract. BaP
is then eluted from the macrophages with resul-
tant tumors ofthe upper respiratory tract. Thus in
attempting to clear BaP from the lung, the macro-
phages serve to concentrate the carcinogen in one
area of the lung.
Toxic Effects: Carcinogenicity
Introduction
The primary route ofgeneral human exposure to
BaP is inhalation, although in occupational situa-
tions (e.g., coal tarplants, roofing, and roadbuilding
operations) skin contact with BaP and related pol-
lutants is important and has resulted in skin can-
cers, dermatitis, and photoallergy (4). BaP causes
chronic effects in the lung, of which the most
significant is lung cancer. There is, however, evi-
dence that POM including BaP-in combination
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with other pollutants-may cause chronic bronchi-
tis and emphysema. This evidence comes mainly
from epidemiological studies of gas and coke oven
workers (15) as well as from investigations of the
general population showing increased nonneoplas-
tic chronic respiratory disease in polluted urban
areas (64, 65). Because lung cancer is the toxico-
logical effect of greatest concern (6), this section
will focus on animal and human data most relevant
to that effect. In order to better understand the
significance of various studies discussed, it is use-
ful to devote some attention first to the basic mech-
anisms by which BaP is now understood to act.
Metabolism of BaP
A large and coherent body ofinformation on the
metabolism of BaP has been developed since the
1930's. This work has been carried out largely in
the rodent and in the human-in the whole ani-
mals, cells and organs in culture, and various tis-
sue preparations. According to Sims and others,
the overall pattern of metabolism in species and
B
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FIGURE 1. Predictions of deposition of particles in the lung. Regional deposition predictions based on the widely used model
proposed by the International Commission on Radiological Protection Committee II Task Group on Lung dynamics indicating
effect of variations in og and flow rate. (A) Each of the shaded areas indicates the variable deposition for a given mass median
(aerodynamic) diameter in each compartment when the distribution parameter o varies from 1.2 to 4.5 and the tidal volume is
1450 ml. (B) Two ventilatory states, 750 and 2150 ml tidal volumes, (ca. 11 and 32 1./min volumes, respectively) are used to
indicate the order and direction o-fchange in compartmental deposition that are indicated by such factors. The tidal volume (the
volume of air that is inspired and expired) is an important respiratory parameter. The deeper inhaled air goes and the longer it
stays, the greater the deposition ofparticles (54, 55).
December 1981 169systems tested is the same (66, 67).
As early as the 1950's, animal studies showed
that BaP is covalently bound to DNA, RNA, and
proteins ofthe cells in target tissues (68). In 1964,
Brookes and Lawley demonstrated that the extent
of covalent binding of polycyclic aromatic hydro-
carbons to DNA in mouse skin was correlated with
carcinogenic potency (69).
In 1966, the Millers from the University of Wis-
consin Medical Center discovered that a number of
chemical carcinogens exert an effect only after met-
METABOLISM
PRECARCINOGEN
I PROXIMATE _INACTIVE
CARCINOGEN(S) ;__0METABOLITES
ULTIMATE CARCINOGEN(S)
[electrophilic(electron-deficient), mutagenic]
| nucleophilic (electron-rich) atoms
in cellular macromolecules
CARCINOGEN RESIDUES BOUND COVALENTLY TO
INFORMATIONAL MACROMOLECULES (DNA's, RNA's,PROTEINS)
CARCINOGENESIS
I mechanisms: genetic?, epigenetic?,
4 virol-genetic?, viral-epigenetic?j
TUMORS
FIGURE 2. Overall metabolism of the majority of chemical
carcinogens (75).
BP - nucleic acid
(guanine and adenine)
Macromolecules
BENZO(a)PYRENE Oxygenase BP
V BP"
I
7,8 -benzoflavone
BP-PHENOL
Conjugates
abolic activation in vivo to an electrophilic form
capable of reacting with nucleophilic residues in
protein and nucleic acids to form covalent adducts
(70, 71). The overall metabolism is summarized in
Figure 2. Their work and that ofother researchers
has brought wide acceptance of the general con-
cept that most chemical carcinogens act through
strong electrophilic metabolites able to bind cova-
lently to cellular macromolecules, the most proba-
ble target being DNA (68, 72). Considerable evi-
dence suggests that covalent adduct formation
represents both the initial and critical step in chemi-
cal carcinogenesis (72-74).
The requirement for metabolic activation was
directly illustrated for BaP by two independent
researchers who found that when BaP is incubated
in a test tube with DNA, binding does not occur
until addition of the microsomal mixed function
oxidase system (MFO) (68, 76, 77). More recently,
negative results for BaP using several in vitro test
systems for mutagenicity in the absence of micro-
somal preparation have illustrated the importance
of metabolism by the MFO (78, 79).
In 1957, Conney and colleagues described the
oxidative metabolism of PAH by enzymes located
in the endoplasmic reticulum (80). Since then, this
enzyme system has been shown to consist of sev-
_u.* BP - protein
-OXIDE hydrase I
I
I
cyclohexene oxi
styrene oxide
TCPO
Glutathione
BP - DIOL
del
Conjugates
BP- Glutothione
Conjugate
FIGURE 3. Microsomal metabolism ofBP, leading to detoxification products and to nucleic acid binding. BP-protein and BP-nucleic
acid designate the reaction products ofBP with protein and nucleic acid respectively; TCPO = trichloropropylene oxide. Current
evidence indicates that BP = 7,8-diol can recycle through the oxygenase system to form the oxide BPDE. BPDE is the major BP
metabolite involved in nucleic acid binding (73).
170 Environmental Health Perspectiveseral forms of cytochrome (P-450) and an electron
transport chain. The function of the P-450 or aryl
hydrocarbon hydroxylase (AHH) is to catalyze the
oxidative metabolism of BaP (as well as other
xenobiotic and even some endogenous compounds)
in order to eliminate these substances (81). This is
accomplished through conversion ofthe initial lipid
soluble substance to a more water soluble form
that can be excreted or conjugated with more polar
groups and then excreted (73, 82) (Figure 3).
As shown schematically in Figure 3, the initial
intermediates in this oxidative process are epox-
ides which alternatively hydrate by an enzyme-
epoxide hydrase (EH) to dihydrodiols, rearrange
to phenols, or react with glutathione. Once dihy-
drodiols are formed, they are either further oxy-
genated to diol epoxides, or are conjugated with
water soluble entities and removed (73, 79, 83, 84).
The diol epoxide intermediates are capable of
reacting with cellular nucleic acids and proteins to
form covalent adducts. Thus, ironically, in carry-
ing out the basic function of detoxifying BaP, the
MFO causes a fraction of them to become active
carcinogens.
The MFO level and activity are altered by a
variety of drugs, pesticides, food additives, ste-
roids and even by exposure to particles and ciga-
rette smoke (85, 87). Enzyme activity is also af-
fected by age, sex, hormonal balance, nutritional
status, and genetic factors (88).
The MFO's are present in most mammalian tis-
sues and have been identified in the liver, placen-
ta, lymphocytes, monocytes, and lung macrophages
in humans (79). Of possible significance is the re-
cent finding that the cytochrome P-450 system is
localized in the nonciliated bronchiolar epithelial
cells of the small airways of the rabbit lung at
much higher concentrations than in other organs
or cell types studied. According to the authors,
this might be an important determinant in the
susceptibility of the lung to a number of toxic
chemicals that require metabolic activation (89).
As early as 1950, Boyland proposed an epoxide
intermediate for carcinogenic PAH (90). Over the
past seven years, studies in Great Britain and the
U.S. have indicated that the critical metabolite of
BaP is not a simple oxide but a dihydrodiol epox-
ide capable of interacting with tissue constituents
-not at the K-region as initially thought -but at
the oxygen situated in the bay region (91) [Eq.
(2)].
According to Miller (1978), elegant studies from
the laboratories of Brookes, Conney, Gelboin, Har-
vey, Jerina, Sims and Grover, and Weinstein now
implicate diol epoxide I [7,8-dihydroxy-9,10-epoxy-
7,8,9,10-tetrahydrobenzo(a)pyrene, also known as
diol epoxide 2, BPDE I, BPDE 2, and "anti-isomer"
due to inconsistencies in terminology among dif-
ferent laboratories] as a major ultimate electro-
philic, mutagenic and carcinogenic metabolite of
BaP whose major reaction products involve the
2-amino group of guanine residues and C-10 of the
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171epoxide and to a lesser extent, adenine and cyto-
sine residues (72).
DOT
HO
6H
r-7,t-8-dihydroxy-t-9,10-oxy-
7,8,9,10-tetrahydrobenzo[a ]pyrene
diol-epoxide I
anti isomer
(±)7,8p-dihydroxy-9p,10ft-epoxy-
7,8,9,10-tetrahydrobenzo[a]pyrene
(±)7p,8^-dihydroxy-9e,10-epoxy-
7,8,9,10-tetrahydrobenzo[a]pyrene
diol-epoxide 2
HOv
OH
HO"
OH
r-7,t-8-dihydroxy-c9,10-oxy-
7,8,9,10-tetrahydrobenzo[a jpyrene
diol-epoxide II
syn isomer
(t)7s,8p-dihydroxy-9a,lOa-epoxy-
7,8,9,10-tetrahydrobenzo[a jpyrene
(t)7p,8a-dihydroxy-9p,,1Op-epoxy-
7,8,9,10-tetrahydrobenzo[a ]pyrene
diol-epoxide 1
Recently, the complete chemical structure ofthe
major adduct formed between benzo(a)pyrene diol
epoxide (BPDE) and cellular nucleic acids has been
shown to be that in Figure 4 (92, 93). The adduct
pictured results from the binding ofthe antiisomer
or diol epoxide I. It is the predominant adduct
consistently found in mammalian and human cells
exposed to BaP in vitro (94).
Unlike acetylaminofluorine, which causes signi-
ficant distortion in the DNA helix following displace-
ment of a base in the DNA, BaP bound to guanine
appears to be accomodated outside the DNA
R
FIGURE 4. Schematic representation of the guanosine-BP ad-
duct formed from the reaction of BP-diol epoxide I with
polyG (92).
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helix-probably in the minor groove as in Figure
5B (95). This accomodation may explain the rela-
tive persistence ofthe adduct in that the cell does
not single out minor distortions for repair.
It is not known whether the consequence of
BaP-DNA binding is a genetic, epigenetic, or yet
another change that results in carcinogenesis (96).
The possible outcomes are the following: (1) DNA
repair mechanisms are triggered: if prompt and
error-free, no effect results from binding. (2) DNA
repair mechanisms are triggered: iferror-prone or
delayed repair occurs, impairment in DNA tem-
plate activity results in mutations in the daughter
cell (97, 98) or impairment in template activity
results in interference with RNA transcription.
This causes distortion in gene transcription and
the pattern ofgene expression (73).
The limited available information on the rate of
repair of DNA following BaP binding indicates
that efficiency of excision is poor: in one study
using cultured human lung cells, 55% ofthe BPDE-I
adduct remained 72 hr after exposure (99), while
in two other investigations, 80% of BPDE-I-dG
adduct was present in human lung cell cultures
after 30 hr (100), and 35% remained in human
bronchus cells after 10 days (87). In mouse skin
cultures, little if any loss of BP-DNA adduct was
V1 t
A B
FIGURE 5. Schematic representations of a DNA double helix
containing (A) benzo(a)pyrene physically bound by interca-
lation and (B) covalently bound benzo(a)pyrene diol epoxide
residue lying in the minor groove of the helix (95).
Environmental Health Perspectivesobserved for 49 hr (101). Similarly, Poirier et al.
(102) observed approximately 40% removal of
BPDE-I adduct after 23 hr in mouse epithelial
cells in culture. Strauss and co-workers (103) esti-
mated that about 0.5% of lesions are removed per
hour, probably via the nucleotide excision path-
way.
Studies of human cells in culture have demon-
strated that covalent binding occurs in many types
of cells: in lung cells (104), in pulmonary alveolar
macrophages (87), in skin cells (105), in peripheral
monocytes (106), and in pancreatic cells (107).
Second, the amount ofadducts formed in human
cells in culture is dependent on dose of BaP, and
length of exposure, as well as the presence of
certain binding inhibitors (benzoflavone and anti-
oxidants such as vitamin E) as well as inducers
(e.g., cigarette smoke, and benzo(a)anthracene) (87,
104).
Third, human cell studies show broad interindivid-
ual variation in the amount of binding: 75-fold in
cultured bronchial cells (87, 104), and 44-fold in
peripheral lung cells from lung cancer patients
(108).
It has been suggested that genetic variations in
the activity of AHH can be correlated with risk of
lung cancer. Kellerman et al. have reported a tri-
modal distribution of AHH inducibility in cultured
human lymphocytes ofhealthy individuals and lung
cancer patients, with 96% of lung cancer patients
having intermediate or high AHH activity as com-
pared with 55% of healthy individuals (109). The
authors suggested that people with high AHH ac-
tivity are at greater risk of lung cancer because
they produce more carcinogenic epoxides than the
low AHH group (110). Work by Trell et al. with
laryngeal cancer patients would seem to confirm
this finding (111).
However, much subsequent research has not sup-
ported this theory. Paigen et al. (112, 113) have
carried out a series of studies of the role of AHH
in relation to cancer risk and failed to find a ge-
netic tendency to high AHH inducibility (that could
be passed on to their children) in patients with
lung or laryngeal cancer. According to Gurtoo et
al. (114) the AHH assay predominantly measures
phenols rather than the carcinogenic metabolites.
Induction of the proximate carcinogen also does
not parallel that ofphenols. Therefore, citing Miller
(1978), they conclude (114): "A more direct mea-
sure of BP activation to carcinogenic metabolites
could be a DNA-binding assay, since DNA binding
may be a critical step in tumor initiation by chemi-
cal carcinogens." This is an echo of an earlier com-
plaint about uncertainties in estimating the effect
of BaP in air pollution. A task group convened to
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assess the relationship between lung cancer and
air pollution stated (10): "This estimation process
could be substantially improved if measurements
could be made of levels of ultimate carcinogen at
the point of activity (perhaps the nucleus oftarget
cell) both experimentally, and in man . . ."
Recently, Poirier et al. (102) have developed an
assay which can estimate the amount of BP-DNA
adduct in tissue using a competitive radioimmuno-
assay technique. According to the authors (102),
this method may provide a tool for use in epidemi-
ological studies investigating the "biological conse-
quence ofhuman exposure to specific chemical car-
cinogens through assay of DNA from cells and
from tissues of exposed individuals."
Experimental Evidence of
Carcinogenicity of BaP
AnimalStudies. Animal data show BaP to pro-
duce tumors in all nine species for which data is
reported and by all routes ofadministration. Work
with experimental animals has elucidated the me-
tabolism and the dose-response relationship ofBaP
and has allowed a partial understanding of the
mechanisms involved in carcinogenesis. The vast
literature has been well reviewed by the NAS (4)
and the IARC (6).
Investigations using experimental animals have
demonstrated several principles relevant to the
role of ambient BaP in lung cancer.
(1) BaP is an initiating carcinogen whose effect
is enhanced or promoted by various other chemical
substances. BaP has been shown to be a potent
carcinogen effective in a single dose and, when
administered transplacentally, able to cause cancer
in the offspring after birth (6). Skin painting stud-
ies have demonstrated that induction of cancer by
low doses of BaP is a multistep process: in one
experiment, a single low dose of BaP to mouse
skin produced no tumors, while subsequent treat-
ment with a promotor (phorbol ester) produced
carcinoma (115).
In the environmental situation, BaP is found in
conjunction with SO2 and other irritant gases and
particles capable of enhancing its effect. Laskin et
al. (116) have produced excess squamous cell car-
cinomas in rats exposed by inhalation to 10 mg/m3
of BaP plus 3.5 ppm SO2 by further increasing the
exposure to SO2. The authors believe that these
findings are significant since both materials are
found in community air, and exposure of animals
resulted in the type of carcinoma predominantly
found in man. This study suggests that SO2 acts
synergistically with BaP by slowing ciliary action
173and increasing BaP retention and/or by causing
chronic injury to the cell so that regenerating cells
are more susceptible to the carcinogen (15, 117).
According to Hoffmann and Wynder, in addition to
So2, 18 substances identified in urban air are toxic
to the lung's mucociliary clearance system; these
include formaldehyde, acrolein, and phenols (7).
Nitrogen oxides (118) as well as certain acid sul-
fates and nitrates are strong irritants (119, 120)
and could also act to enhance the carcinogenic ac-
tion of BaP.
(2) The carcinogenic effect of BaP is related to
dose; no study has demonstrated a threshold dose
for BaP; and the effect of low, divided doses may
be greater than that for a single high dose. Mon-
tesano et al. (121) and Feron et al. (122) have
observed a dose-response in hamsters given increas-
ing levels of BaP and ferric oxide. In the latter
study, a clear dose-response relationship emerged
with the lowest dose of 3.25 mg total per lifetime,
eliciting a 10% response in the exposed animals
compared with 0% incidence in controls. Yanysheva
and Antomonov (123) reported excess tumors in
rats exposed to a total dose of0.5 mg. In an earlier
dose-response study with BaP and hematite, Saffiotti
and co-workers (124, 125) observed excess tumors
at the lowest dose of 0.25 mg BaP per week with
11% of the animals affected. This investigation
failed to demonstrate a no-effect level (6).
Analysis ofBaP retention rates in hamsters show
that the carcinogen is eluted more rapidly from the
carrier particulate when given in small doses (126).
This may explain why low doses of BaP have been
more effective per unit dose in several studies.
Studies by Saffiotti et al. (124-126) indicated that a
given total amount of BaP combined with iron
oxide produced tumors earlier when given in small
divided doses by frequent instillations than when
given in a single administration. Forexample, when
Saffiotti, Montesano, and colleagues administered
a single dose of 5 mg BaP with ferric oxide
intratracheally, they found a 4% incidence of re-
spiratory tumors with the first tumor appearing at
52 weeks (124, 125). By contrast, when they frac-
tionated a total dose of 5 mg BaP into 20 adminis-
trations, an 11% incidence resulted; the first tumor
was found at only 22 weeks. Similarly, a total
benzpyrene dose of 0.1 mg administered to rats
once and in five fractions did not produce tumors,
but a tumorigenic effect was seen when 0.1 mg
was administered in ten fractions (123). The Task
Group (10) cites further evidence of this effect in
the work of Bryan and Shimkin (127), Yanysheva
(128), and Payne and Heuper (129). The group
considered these experiments showing enhanced
effect ofrepeated, low doses of BaP to be relevant
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to their assessment of risk to humans from con-
stant exposure to low levels of BaP in the atmo-
sphere.
(3) Interaction between BaP and fine particu-
late particles results in an increased carcinogenic
effect. Synergism has been demonstrated in ani-
mal studies in which BaP carried by particulates
(such as carbon or iron oxide particles) produces a
more pronounced carcinogenic effect than BaP alone
(4, 63, 121). In studies with hamsters, Saffiotti and
co-workers (63) observed bronchogenic carcinoma
in all hamsters (surviving after 16 weeks) exposed
to an equal mixture of BaP and ferric oxide parti-
cles, whereas ferric oxide particles alone did not
produce any tumors.
Polluted air contains BaP and large quantities of
fine particulates including carbon, hematite, and
trace metals, all in the presence of irritant sulfur
and nitrogen oxides, phenols, etc. (130). Coffin (62)
has observed that the ingredients necessary for
lung cancer in animals are present in urban air.
In Vitro Studies. Since the early 1970's, BaP
has tested positive in over twenty in vitro short-
term test systems considered to be predictive of
potential human carcinogenicity (133).t These in-
clude assays formutagenicity in bacterial and mam-
malian cell systems; tests for DNA damage; and
assays for cell transformation. In all of these sys-
tems, metabolic activation using enzymes or co-
cultivation was necessary. Extracts of airborne
particulate-of which BaP is a component-have
also given positive results in in vitro tests for
mutagenicity/carcinogenicity (134). Recently, Tokiwa
et al. (135) studied the mutagenicity ofvarious size
fractions of airborne particulate collected at an
industrial site; they found thatthe size range 0.1-0.3
,um in diameter contained the, highest concentra-
tion of BaP and was ofmaximal mutagenic activity
in the Ames assay.
Extracts of diesel particulate, which contain
significant amounts of BaP, have given positive
results in an array of short-term in vitro tests
(136, 137). Most studies have been made of diesel
particulate extract rather than diesel particulates
themselves. However, McCornick (138) has reported
that diesel particulates incubated with normal human
cells and with DNA-repair deficient (XP) human
cells, respectively, caused differential toxicities.
These results indicated that substances capable of
tFor example, mutagenicity in the Ames Salmonella
typhimurium bacterial assay is widely considered to be an
indicator of carcinogenicity because of the high correlation
(around 90%) between the two effects (131). Purchase et al.
(132) found a similar correlation between transformation of
cells in culture and carcinogenicity.
Environmental Health Perspectivesdamaging human DNA were eluted offthe particle
within the cell.
Mutagenicity/carcinogenicity ofvarious BaP me-
tabolites has been demonstrated in numerous in
vitro assays from the early 1970's on, allowing
comparisons of potency. For example, Jerina and
colleagues (139) have reported higher mutagenic-
ity in 7,8-diol-9,10-epoxides of BaP and 7,8-dihy-
drodiol compared to other derivatives ofBaP tested
in vitro. Other short-term assays for mutagenicity
have been positive for BaP. For example, Rudiger
et al. (105) reported that BaP induces sister chro-
matid exchange in cultured human lymphocytes.
In 1965, Berwald and Sachs reported that cells
transformed by PAH produced tumors when in-
jected into the whole animal (140). Investigators
have subsequently shown a direct relationship be-
tween the extent oftransformation in cultured cell
colonies and carcinogenic potency (4). Extracts from
both urban and workplace air and BaP itself have
also transformed cells in vitro (4, 15). A recent
study reported that cigarette smoke extracts en-
hanced transformation of cultured cells exposed to
benzo(a)pyrene (141).
Human Evidence of the
Carcinogenicity of BaP
Concerning epidemiological evidence on the car-
cinogenicity ofBaP, there are numerous epidemio-
logical studies of workers exposed to mixtures of
BaP and other pollutants; a body of data relating
to the effects ofgeneral air pollution; and, ofcourse,
the vast literature on smoking. All are relevant to
the inhalation toxicology of BaP since all three
situations involve exposure to BaP as a potent
initiating carcinogen in combination with irritant,
ciliatoxic, and carcinogenic ingredients (7, 15, 142).
The results of studies of workers exposed to
BaP in a mixture ofpollutants released during coal
gasification, coke oven and roofing operations show
a dose response with relative risks of 33-fold in
Japanese gas workers (143) and 16-fold in coke
oven workers with the highest cumulative expo-
sure, compared to unexposed controls (15, 144,
145). Epidemiological investigations of workers ex-
posed to diesel emissions are inconclusive to date
because of methodological problems including fail-
ure to allow for the latency period of lung cancer
(146) (Table 4).
There have been no detailed epidemiological
studies ofcommunity exposure to industrial sources
of BaP. Suta (150) has estimated, however, that
the 17 million people living near coke ovens in the
U.S. inhale from 3-1,500 ng BaP annually and
about half inhale greater than 100 ng BaP daily.
A number of epidemiological studies have com-
pared the lung cancer experience of people living
in areas with differing levels of BaP and related
pollutants (42, 151-155). All but Higgins (154)
Table 4. Summary of epidemiological studies of workers exposed to diesel emissions.
Effect and population
studied Exposure classification Results Caveats Reference
Mortality and morbidity in Men were grouped in order A total of 96 deaths were The number ofcases was very (147)
London Transport staff of estimated exposure to from lung cancer, ill-health small; the study did not take
exposed to diesel; men aged exhaust fumes based on retirements, and transfers into account the long latency
45-64 were studied from general observation and due to lung cancer; highest period oflungcancer; smoking
1950-54 not chemical estimation rate was in 2nd least histories were not taken
exposed group (trolleybus
engineering staff);
no excess was found
in highly exposed group;
association was found with
place of residence
Mortality in U.S. railway Workers were divided into The least exposed group Selection in retiring ill (148)
workers; 154 deaths 3 groups based on had the highest lung employees was not evaluated;
between 1953-58 due to estimated exposure cancer mortality; an smoking was not considered;
cancer oflung association was found with other causes of death which
and/or bronchus residence in urban areas compete with lung cancer
were studied. were not evaluated; small
number of deaths
Mortality in potash workers Workers in dieselized mine No excess mortality from Mines dieselized only since (149)
from 8 mines-2 dieselized were compared with non- lung cancer was found in 1949 and 1957 (insufficient
-was studied for the dieselized exposed workers time for induction?); small
period 1940-1967 number of deaths (31) may
preclude significant results
December 1981 175found a significant correlation between lung cancer
mortality and BaP and/or related pollutants.
Stocks (151) compared lung cancer death rates
in Liverpool and rural North Wales. BaP levels
were 77 ng/m3 and 7 ng/m3 in the respective areas.
Compared with their counterparts in North Wales,
nonsmokers in Liverpool had a 127% excess in
lung cancer mortality or 28 extra deaths per
100,000 population. For smokers ofone-half a pack
daily, the increase in the urban residents was even
greater: 143% or 100 additional deaths per 100,000.
These data suggest that the effect of air pollution
and cigarette smoking is synergistic rather than
additive (8).
Another investigation by Hitosugi concluded
that there was an 80% increase in lung cancer
death rates in the residents of the area with high
BaP pollution when age and smoking were taken
into account (42). No differences were seen in
rates for non-smokers (possibly because of the
small numbers of deaths in this category), but
smokers in the high BaP area experienced 80-120%
higher death rates compared to those in the less
polluted area.
These figures must be regarded as estimates
only because of the many potential confounding
variables and the inadequacies in monitoring data.
For reasons mentioned earlier, there may be
significant errors in the air concentration levels on
which the studies are based. According to the
OTA, if the errors in air monitoring are random,
they could result in a significant understatement of
the effect on health (21).
A dose response has been clearly demonstrated
for cigarette smoking and lung cancer (156, 157).
Based upon results of epidemiological studies,
Wynder and Stellman (158) estimate the relative
risk oflung cancer to be as great as 18 for nonfilter
smokers of 1-10 cigarettes daily compared with
nonsmokers.
Pike et al. (8) compare the amount of BaP a
nonsmoker in 1959 would have inhaled daily from
the ambient air of St. Louis, Missouri (810 ng),
Montgomery, Alabama (360 ng) and Dallas, Texas
(21 ng) with the amount of BaP inhaled by a
smoker of one pack of nonfiltered cigarettes daily
(600 ng). They conclude that "If a nonsmoker in
Montgomery breathed the air as if he were smok-
ing, then in terms of BaP taken in, it would be
roughly equivalent to a smoker of one-half a pack
daily in Dallas." Following this logic, and applying
the relative risk derived by Wynder and Stellman
(158) above, we could estimate that the risk of
lung cancer for an individual non-smoker in Mont-
gomery in 1959 was at least 18 times that of a
non-smoker in Dallas. Ofcourse, such a calculation
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assumes that BaP is a reliable and comparable
index ofcarcinogenicity ofbothmixtures-cigarette
smoke and air pollution.
Because the assumptions involved in such an
extrapolation are so large, several investigators
have turned to occupational and general population
epidemiology in an attempt to develop estimates of
the risk of BaP at levels encountered in ambient
air (8, 152). Using data from Stocks (151), Pike et
al. have derived a dose response function for
ambient BaP, i.e., that each increment of 1 ng/m3
BaP causes 0.4/100,000 and 1.4/100,000 extra lung
cancer deaths per year in nonsmokers and in
smokers, respectively (8). The figure of0.4/100,000
was consistent with Pike's calculations based on
studies of British gasworkers carried out by Doll
and co-workers (159). However, as can be seen
from Tables 5 and 6 these exercises also entail
large assumptions as well as uncertainties in the
data and cannot, therefore, be accepted as any-
thing more than range-finding.
Although these epidemiological studies do not
provide the basis for quantitative risk estimates,
they are consistent with two important findings of
studies in experimental animals. First, the greater
relative risk of lung cancer experienced by coke
oven workers as compared with British gasworkers
-16-fold versus twofold-may be a reflection of
concurrent exposure to high levels of SO2 in coke
oven plants. By contrast, SO2 was not far from the
"normal" urban range in the gasworks.15 This
observation can be related to experimental findings
of synergistic interaction between BaP and SO2 in
the production of tumors by Laskin et al. (116).
Second, as mentioned above, data of Stocks,
Hitosugi and others point to a synergistic relation-
ship between BaP and cigarette smoking (8, 160).
Further evidence is provided by a retrospective
(case-control) study of lung cancer deaths in Japan
that concluded that smokers in polluted areas had
a 6-fold risk of lung cancer compared with non-
smokers; if atmospheric contamination was added
to cigarette smoking, the risk of lung cancer
increased to about tenfold. In the absence of
smoking, the relative risk of lung cancer for those
living in the high pollution area was only 2.5 (161).
Difficulties in Quantitative Assessment
of Risks of BaP
Although EPA's proposed cancer policy for car-
cinogens in the air incorporates quantitative risk
assessment as the basis for regulatory decision-
making (162), the Clean Air Act Amendments of
1977 do not require such assessment before EPA
can take action to regulate a hazardous or carcino-
Environmental Health PerspectivesTable 5. BP dose-response estimates derived from general air pollution epidemiology.
Estimate Assumptions or comment Reference
Increases in lung cancer death rate in smokers per BaP A unit BP is defined here as 7.0 ng/m3 BP; therefore an (4, 152)
"unit" range from 10% (light), 5.5% (moderate), 1.1% excess 14.5 deaths/100,000 would be associated with
(heavy) to 13% (nonsmokers). For moderate smokers 1 ng/m3 BP. Average increase per ng/m3 BP
a "unit" BaP was associated with an excess in smokers is 5.5%.
104/105 lung cancer deaths.
An estimated 1.4/105-0.4/105 extra deaths are attributable Results for nonsmokers are remarkably consistent with (8)
to 1 ng/m3 BP in smokers and nonsmokers, those derived from British gas workers data; differences in
respectively. duration of exposure might explain 3-4 times higher results
obtained here for smokers in general population compared
with smokers among gas workers.
A 4% increase in the lung cancer death rate in smokers is Hitosugi recorded an average 60% increase in lung cancer (4, 152)
associated with 1 ng/m3 BP. mortality for smokers (120% for light smokers) in areas of
high BP; the difference in annual average BP levels in high
vs. low pollution areas was 16 ng/m3 (estimated as 30% of
yearly maximum). (For light smokers taken as a separate
class, a 7.5% increase inlungcancermortalitywas associated
with a 1 ng/m3 increase.)
Table 6. BP dose-response estimates derived from occupational epidemiology.
Estimate Assumptions or comment Reference
Extrapolation from observed excess 160/105 lung cancer Workers were exposed to2000ng/m3 BPforabout22% ofthe (8)
cases in British gas workers from exposure to the year(assuming40-hr. workweekwith3weeksannualleave);
equivalent of 440 ng/m3 BP in general air pollution therefore exposure was 2000 x 0.22 or 440 ng/m3 BP. Pike
gives an estimated 0.4/105 extra lung cancer cases/yr did not correct for the fact that gas workers were not
per ng/m3 BP in the general population. exposed all their lives.
Based upon excess (7118/105) deaths by Lloyd among Author took 24% of minimum BP level measured on top of (155)
coke oven workers exposed to the general air pollution coke ovens; he assumed roughly the same relationship
equivalent of224 ng/m3, a 24.7/105 increase in deaths between worker and general population exposure as
is associated with 1 ng/m3 BP in the general Pike (8).
population.
genic air pollutant (163). Further, there are very
real difficulties in performing quantitative risk as-
sessment for BaP or any other airborne carcinogen
using methods and data available at this time. For
reasons already alluded to, the experimental and
epidemiological data such as those described in the
previous section allow the identification of BaP as
an important atmospheric carcinogen but do not
provide the basis for a reliable estimate of the
magnitude ofthe risk because ofthe many sources
ofuncertainty and error in such an exercise.
Using Experimental Data. First, the reliabil-
ity of extrapolation from data derived from animal
studies to man is limited by the following uncer-
tainties.
(1) PROBLEMS IN EXTRAPOLATING FROM HIGH
DOSES IN SMALL ANIMALS TO Low DOSES IN
MAN. Mathematical models developed to extrapo-
late the results of high-dose, small-scale animal
studies (necessary for practical reasons) to low-
level exposure of the general public differ by a
factor of 100,000 in projections of the dose that
would cause one extra cancer in a million animals
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(164). According to Comfeld (165), "no firm scientific
basis now exists for choosing among them." Fur-
thermore, despite the fact that the common as-
sumption ofa linear relationship between dose and
response (166, 167) is generally believed to be con-
servative, there is evidence that repeated lower
doses of a carcinogen (and BaP specifically) are
actually more effective than higher doses (10).
An additional problem is the need to "relate"
doses in small animals to man. It is unclearwhether
this should be done on the basis of relative body
weights, surface areas, lifespans, or some other
method (163, 168).
Inability to resolve such questions has led to the
conclusion by the National Academy of Sciences
(169) that the risk of consuming saccharin in one
can of diet soda per day could lead to as few as
0.0007 cancers per year in 50 million people, or as
many as 3,640. This is a range of error greater
than a million-fold (163).
(2) UNKNOWN DIFFERENCES IN SPECIES SEN-
SITIVITY AND POSSIBLE METABOLIC DIFFERENCES
AMONG SPECIES AND STRAINS WITHIN SPECIES.
177Animal species can have marked differences in
sensitivities to carcinogens-as great as two or
more orders of magnitude. There is, in fact,
evidence that man may be the most sensitive
species to certain chemical carcinogens (10). Varia-
tion in sensitivity-combined with unpredictable
differences in metabolic, pharmokinetic, and repair
mechanisms between species-is a significant
source ofimprecision.
(3) FAILURE TO CONSIDER INTERACTIONS AND
SYNERGISM BETWEEN ENVIRONMENTAL AGENTS.
Whereas animal experiments are generally carried
out with one test substance in a controlled envi-
ronment, humans are exposed to a variety of
interacting and synergistic agents. BaP is a prime
example of an atmospheric carcinogen capable of
interaction with other pollutants as well as factors
such as smoking. The Council on Environmental
Quality regards this factor to be a major obstacle
to quantitative risk assessment (170).
(4) FAILURE TO CONSIDER INTERINDIVIDUAL
VARIATION IN SENSITIVITY OF HUMANS. There
is no established method of measuring differences
in human sensitivity to carcinogens; yet it is well
known that humans are genetically heterogeneous
and are therefore suspected to have a wide varia-
tion in response. By contrast, interindividual vari-
ation has been reduced or eliminated in most
experimental lines by breeding in order to arrive
at a genetically homogeneous test population.
Therefore, the unknown but presumably broad
range of human sensitivities is a source of uncer-
tainty in extrapolating from animal data.
UJsing Human Data. Similarly, limitations of
human epidemiological studies preclude reliance upon
their findings for quantitative risk assessment. Un-
dertaken as they are in a complex natural setting,
epidemiological studies are hindered by a large
number of variables that can obscure true rela-
tionships between a causal agent and disease (171,
172). Further, because only limited study popula-
tions are generally available, it is difficult to detect
modest increases in an effect such as lung cancer
which may nonetheless be important in a large
population (173). Even large-scale studies have lim-
ited ability to detect a real excess cancer rate of
less than 50% (174).
Another frequent problem is the failure to con-
sider the latency period of cancer (often on the
order ofdecades) and concluding, wrongly, that no
excess risk exists. Finally, in epidemiological stud-
ies involving environmental pollutants such as BaP,
precise exposure or "dose" data are not available
for.the dual reason that monitoring data are inad-
equate and because duration of exposure is rarely
known.
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Based upon data from four epidemiological stud-
ies and three animal experiments, the CAG de-
rived an estimate of 200 deaths per year nation-
wide attributable to POM (175). For all of the
reasons just discussed, such a risk estimate must
be viewed with caution.
The impossibility of quantifying the risk of BaP
automatically precludes valid economic "cost benefit"
analysis. Nor is balancing of costs and benefits
required in regulating hazardous pollutants under
Section 112 ofthe Clean Air Act. According to the
OTA such an exercise would probably produce spu-
rious results which would tend towards significant
understatement of the benefits of regulating BaP
because, whereas we know the economic costs of
controls, we can not now know the environmental
and health "costs" of foregoing controls (21).
Control of BaP
Inefficiency of Present Controls
Existing controls for stationary fossil fuel com-
bustion sources are aimed at achieving weight-
based emissions or ambient air quality standards
for total suspended particulate matter and there-
fore tend to control coarse particles at the expense
of the fine particulate component. For example,
according to Kornreich, when high efficiency par-
ticulate controls are used together, 83% of the
particles emitted are smaller than three microme-
ters in diameter (176). Pike et al. (8) have ob-
served that "the bulk of BaP now in the air is
associated with particles that do reach the lungs,
but this was probably not true when large soot
particles were still commonly present in the atmo-
sphere." (p. 229).
Today 97% ofpower plants have cyclones, scrub-
bers, or electrostatic precipitators (ESP's), fabric
filters, or a combination. Except for fabric filters,
most applications of these technologies tend to be
inefficient for very fine particles with which BaP is
largely associated (130). Cyclones, for example fail
to remove particles smaller than 10 ,um; low en-
ergy scrubbers are inefficient collectors offine par-
ticles (30) and electrostatic precipitators have a
substantial drop in collection efficiency for parti-
cles below 0.5 ,um (177). Furthernore, most BaP
exists as vapor in the stack of a typical power
plant, therefore "hot side" precipitators which op-
erate with gas temperature higher than the con-
densation point for most POM's fail to collect con-
siderable amounts of BaP (30). Fabric filters are
efficient collectors offine particles but may become
Environmental Health Perspectivesblocked by tarry particles or, if operated at high
temperature, may fail to trap vapor BaP (30).
Stationary source control of BaP entails use of
technologies that can effectively condense or collect
BaP vapor (e.g., high energy scrubbers) as well as
devices that can maximize capture of fine partic-
ulates. According to OTA (21), fine particulate
controls alone will probably reduce BaP emissions
by 85-90%.
Forintermediate-size boilers, cyclones and ESP's
are the most commonly used; yet for reasons just
mentioned they are not adequate BaP control meth-
ods. As for residential furnaces, many such boilers
have little or no particulate control of any kind
(30).
In addition to improved technologies that con-
trol emission of BaP vapor and fine particulate
material, adjustments in the type of fuel, change
in combustion process, and use ofafterburners can
be used to reduce BaP (4, 27). In some cases (as in
coke oven operations), hydrocarbons may be re-
covered from effluent streams and recycled (130).
BaP control methods suggested for stationary
diesel engines include water scrubbers and spiral
filter beds (178). BaP controls for diesel-powered
automobile emissions are presently evolving. The
majormethods beingconsidered are the trap oxidizer
(catalytic and noncatalytic), and engine modifications;
while afterburners and fuel modification are also
being explored (179).
The effectiveness of technologies to control BaP
and related emissions from synfuels processing and
combustion plants is so far unknown. High tem-
perature and high pressure particulate control
equipment is being studied but is unlikely to col-
lect BaP efficiently for reasons cited earlier (30).
Another approach to BaP control is to substitute
less polluting energy sources such as natural gas,
solar energy, etc., for conventional sources of en-
ergy. A third solution-in addition to control tech-
nologies and alternative sources of energy-is con-
servation. According to Stobaugh and associates at
the Harvard Business School (180): "If the U.S.
were to make a serious commitment to conserva-
tion, it might well consume 30-40% less energy ...
and still enjoy the same or higher standard of
living. This would require only modest adjustments
in the way people live." (p. 136)
Absence of Standards for BaP
At this time there are no health or environmen-
tal standards for BaP or for fine particulate matter
in the U.S. (130). Therefore, there is little incen-
tive for industry to take steps to control emissions
of these pollutants. The only relevant standard is
the occupational standard for coke oven emissions
(CFR) (181). EPA does not anticipate proposing
standards specific for BaP (182).
The absence of BaP standards in the U.S. is all
the more striking in view ofthe standards adopted
in 1972 and 1973 for the U.S.S.R. consisting of a
maximum exposure level of 1 ng/m3 in ambient air
and a maximum allowable concentration (MAC) of
150ng/m3 in work environments (183). Shabad (183)
stresses the fact that the Ministry ofHealth ofthe
U.S.S.R. does not consider the MAC to be a safe
level but rather to be the "maximum unavoidable
dose." Table 2 shows that U.S. ambient BaP con-
centrations have significantly exceeded the U.S.S.R.
maximum exposure level.
Specifically reviewing the potential human health
impacts of coal combustion, the OTA (21) urges
EPA to carry out the provision of the Clean Air
Act Amendments of 1977 that the Agency study
the health effects offine particles, associated trace
elements, and POM to establish regulatory con-
trols if necessary. Existing data reviewed above
indicate that BaP is a candidate for regulation
under the Clean Air Act (184). The Clean Air Act
provides several means ofregulating BaP: through
a nationwide ambient air quality health standard
under Sections 108 or 109; through standards of
performance for new and existing sources of BaP
(Section 111); or through emissions standards for
hazardous airpollutants under Section 112. Sections
108, 109, and 111 address pollutants which may
"reasonably be expected to endangerpublic health,"
while Section 112 requires EPAto list as ahazardous
air pollutant each substance that "may reasonably
be anticipated to result in an increase in mortality
or an increase in serious, irreversible, or incap-
acitating reversible illness." One or possibly a combi-
nation of these regulatory approaches is necessary
to protect public health from airborne BaP.
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